Syndax Pharmaceuticals (SNDX) PT Lowered to $40 at Jefferies

March 27, 2026 4:14 PM

Jefferies analyst Faisal Khurshid lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $40.00 (from $48.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found